p15(INK4b) in HDAC inhibitor-induced growth arrest

Toshiaki Hitomi1, Youichirou Matsuzaki, Tomoya Yokota

  • 1Department of Molecular-Targeting Cancer Prevention, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto 602-8566, Japan.

FEBS Letters
|November 19, 2003
PubMed

Insights

Histone deacetylase (HDAC) inhibitors activate the p15(INK4b) gene, independent of p21(WAF1/Cip1). This suggests p15(INK4b) is a key target for HDAC inhibitors, impacting tumor cell growth.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Cycle Regulation

Background:

  • Histone deacetylase (HDAC) inhibitors are known to arrest tumor cells at the G1 phase and activate p21(WAF1/Cip1).
  • Evidence suggests a p21(WAF1/Cip1)-independent pathway mediating HDAC inhibitor effects.

Purpose of the Study:

  • To investigate the role of the p15(INK4b) gene in HDAC inhibitor-induced cell cycle arrest.
  • To identify novel molecular targets of HDAC inhibitors beyond p21(WAF1/Cip1).

Main Methods:

  • Treatment of HaCaT cells with HDAC inhibitors (trichostatin A and sodium butyrate).
  • Analysis of p15(INK4b) gene activation via its promoter.
  • Assessment of cell growth inhibition in HCT116 p21 knockout cells.

Main Results:

  • HDAC inhibitors, TSA and sodium butyrate, were found to activate the p15(INK4b) gene in HaCaT cells.
  • Upregulation of p15(INK4b) by TSA correlated with growth inhibition in HCT116 p21 (-/-) cells.
  • These findings highlight a p21(WAF1/Cip1)-independent mechanism involving p15(INK4b).

Conclusions:

  • The p15(INK4b) gene is a significant molecular target of HDAC inhibitors.
  • p15(INK4b) activation represents a crucial pathway in HDAC inhibitor-mediated anti-cancer effects.
  • This study expands the understanding of HDAC inhibitor mechanisms in cancer therapy.

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...